| Oxidative stress, glutamate, and neurodegenerative disorders JT Coyle, P Puttfarcken Science 262 (5134), 689-695, 1993 | 5013 | 1993 |
| Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain PJ Whitehouse, DL Price, RG Struble, AW Clark, JT Coyle, MR DeLong Science 215 (4537), 1237-1239, 1982 | 4543 | 1982 |
| Alzheimer's disease: a disorder of cortical cholinergic innervation JT Coyle, DL Price, MR DeLong Science 219 (4589), 1184-1190, 1983 | 3892 | 1983 |
| Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis PJ Whitehouse, DL Price, AW Clark, JT Coyle, MR DeLong Annals of Neurology: Official Journal of the American Neurological …, 1981 | 2275 | 1981 |
| Oxidative stress in neurodegenerative diseases. NA Simonian, JT Coyle Annual review of pharmacology and toxicology 36, 83-106, 1996 | 1599 | 1996 |
| Lesion of striatal neurons with kainic acid provides a model for Huntington's chorea JT Coyle, R Schwarcz Nature 263 (5574), 244-246, 1976 | 1449 | 1976 |
| The emerging role of glutamate in the pathophysiology and treatment of schizophrenia DC Goff, JT Coyle American Journal of Psychiatry 158 (9), 1367-1377, 2001 | 1252 | 2001 |
| Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia JE Lisman, JT Coyle, RW Green, DC Javitt, FM Benes, S Heckers, ... Trends in neurosciences 31 (5), 234-242, 2008 | 1226 | 2008 |
| Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress TH Murphy, M Miyamoto, A Sastre, RL Schnaar, JT Coyle Neuron 2 (6), 1547-1558, 1989 | 1225 | 1989 |
| Glutamate and schizophrenia: beyond the dopamine hypothesis JT Coyle Cellular and molecular neurobiology 26, 363-382, 2006 | 1173 | 2006 |
| Catecholamines in fetal and newborn rat brain JT Coyle, D Henry Journal of neurochemistry 21 (1), 61-67, 1973 | 1024 | 1973 |
| Neurobiology of schizophrenia CA Ross, RL Margolis, SAJ Reading, M Pletnikov, JT Coyle Neuron 52 (1), 139-153, 2006 | 962 | 2006 |
| Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis JD Rothstein, G Tsai, RW Kuncl, L Clawson, DR Cornblath, DB Drachman, ... Annals of neurology 28 (1), 18-25, 1990 | 872 | 1990 |
| D-serine added to antipsychotics for the treatment of schizophrenia G Tsai, P Yang, LC Chung, N Lange, JT Coyle Biological psychiatry 44 (11), 1081-1089, 1998 | 832 | 1998 |
| Glutamatergic mechanisms in schizophrenia G Tsai, JT Coyle Annual review of pharmacology and toxicology 42 (1), 165-179, 2002 | 765 | 2002 |
| Review of the toxicology of chlorpyrifos with an emphasis on human exposure and neurodevelopment DL Eaton, RB Daroff, H Autrup, J Bridges, P Buffler, LG Costa, J Coyle, ... Critical reviews in toxicology 38 (sup2), 1-125, 2008 | 752 | 2008 |
| The glutamatergic dysfunction hypothesis for schizophrenia JT Coyle Harvard review of psychiatry 3 (5), 241-253, 1996 | 738 | 1996 |
| Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies ML Simmons, CG Frondoza, JT Coyle Neuroscience 45 (1), 37-45, 1991 | 727 | 1991 |
| Memory distortion: How minds, brains, and societies reconstruct the past DL Schacter, JT Coyle Harvard University Press, 1995 | 669 | 1995 |
| Abnormal excitatory neurotransmitter metabolism in schizophrenic brains G Tsai, LA Passani, BS Slusher, R Carter, L Baer, JE Kleinman, JT Coyle Archives of general psychiatry 52 (10), 829-836, 1995 | 623 | 1995 |
